ESR1 and breast carcinoma: As miR-155 expression correlated an ERα− phenotype and Rictor expression correlated with ERα+ tumors, we next investigated whether the observed high levels of miR-155 expression in ERα− breast cancers was a driving force for the repression of Rictor.